HC
Hopkinson Craig C. Directivo
Other M
Historial del iniciado Director General Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Explore the detailed record of transactions filed by Hopkinson Craig C., Directivo. Director active across 2 companies, notably Alkermes plc.. In total, 52 reports have been published. Split: 0 buy · 15 sells. Total volume traded: €4.4m. Activity tracked since 9 June 2021. The latest transaction was disclosed on 3 August 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Hopkinson Craig C. Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declaraciones 52 en total
◇ EVP R&D, Chief Medical Officer · Directivos · 3 ago 2026 · Alkermes plc. 104 títulos @ 19,34 US$ 0.0000% mcap 0.0% de su flujo Ordinary Shares SEC:0001520262-26-000110:0
◇ EVP R&D, Chief Medical Officer · Directivos · 3 ago 2026 · Alkermes plc. 4896 títulos @ 24,59 US$ 0.0015% mcap 1.1% de su flujo Ordinary Shares SEC:0001520262-26-000110:1
▼ EVP R&D, Chief Medical Officer · Directivos · 3 ago 2026 · Alkermes plc. 9000 títulos @ 48,58 US$ 0.0053% mcap 4.1% de su flujo Ordinary Shares SEC:0001520262-26-000110:2
◇ EVP R&D, Chief Medical Officer · Directivos · 1 jul 2026 · Alkermes plc. 5000 títulos Ordinary Shares SEC:0001520262-26-000103:0
▼ EVP R&D, Chief Medical Officer · Directivos · 1 jul 2026 · Alkermes plc. 8300 títulos Ordinary Shares SEC:0001520262-26-000103:1
▼ EVP R&D, Chief Medical Officer · Directivos · 1 jul 2026 · Alkermes plc. 700 títulos Ordinary Shares SEC:0001520262-26-000103:2
◇ EVP R&D, Chief Medical Officer · Directivos · 1 jun 2026 · Alkermes plc. 5000 títulos @ 19,34 US$ 0.0018% mcap 1.2% de su flujo Ordinary Shares SEC:0001520262-26-000097:0
▼ EVP R&D, Chief Medical Officer · Directivos · 1 jun 2026 · Alkermes plc. 9000 títulos @ 41,6715 US$ 0.0070% mcap 4.6% de su flujo Ordinary Shares SEC:0001520262-26-000097:1
◇ EVP R&D, Chief Medical Officer · Directivos · 1 may 2026 · Alkermes plc. 5000 títulos @ 19,34 US$ 0.0010% mcap 1.1% de su flujo Ordinary Shares SEC:0001520262-26-000072:0
▼ EVP R&D, Chief Medical Officer · Directivos · 1 may 2026 · Alkermes plc. 9000 títulos @ 33,3955 US$ 0.0032% mcap 3.5% de su flujo Ordinary Shares SEC:0001520262-26-000072:1
◇ EVP R&D, Chief Medical Officer · Directivos · 1 abr 2026 · Alkermes plc. 5000 títulos @ 19,34 US$ 1.1% de su flujo Ordinary Shares SEC:0001520262-26-000065:0
▼ EVP R&D, Chief Medical Officer · Directivos · 1 abr 2026 · Alkermes plc. 9000 títulos @ 35,5116 US$ 3.6% de su flujo Ordinary Shares SEC:0001520262-26-000065:1
◇ EVP R&D, Chief Medical Officer · Directivos · 2 mar 2026 · Alkermes plc. 5000 títulos @ 19,34 US$ 1.0% de su flujo Ordinary Shares SEC:0001520262-26-000058:0
◇ EVP R&D, Chief Medical Officer · Directivos · 26 feb 2026 · Alkermes plc. 6866 títulos Ordinary Shares SEC:0001520262-26-000046:0
◇ EVP R&D, Chief Medical Officer · Directivos · 23 feb 2026 · Alkermes plc. 7689 títulos Ordinary Shares SEC:0001520262-26-000033:0
◇ EVP R&D, Chief Medical Officer · Directivos · 18 feb 2026 · Alkermes plc. 8897 títulos Ordinary Shares SEC:0001520262-26-000026:0
◆ EVP R&D, Chief Medical Officer · Directivos · 5 feb 2026 · Alkermes plc. 25.352 títulos Ordinary Shares SEC:0001520262-26-000016:0
◇ EVP R&D, Chief Medical Officer · Directivos · 2 feb 2026 · Alkermes plc. 5000 títulos @ 19,34 US$ 1.0% de su flujo Ordinary Shares SEC:0001520262-26-000009:0
◇ EVP R&D, Chief Medical Officer · Directivos · 8 ene 2026 · Alkermes plc. 5000 títulos @ 19,34 US$ 1.0% de su flujo Ordinary Shares SEC:0001520262-26-000004:0
▼ EVP R&D, Chief Medical Officer · Directivos · 2 ene 2026 · Alkermes plc. 4000 títulos @ 28,00 US$ 1.1% de su flujo Ordinary Shares SEC:0001520262-26-000002:0
◇ EVP R&D, Chief Medical Officer · Directivos · 3 dic 2025 · Alkermes plc. 3748 títulos @ 19,34 US$ 0.8% de su flujo Ordinary Shares SEC:0001520262-25-000014:0
▼ EVP R&D, Chief Medical Officer · Directivos · 1 dic 2025 · Alkermes plc. 4000 títulos @ 29,30 US$ 1.3% de su flujo Ordinary Shares SEC:0001520262-25-000012:0
◇ EVP R&D, Chief Medical Officer · Directivos · 3 nov 2025 · Alkermes plc. 5000 títulos @ 19,34 US$ 1.1% de su flujo Ordinary Shares SEC:0001520262-25-000010:0
◇ EVP R&D, Chief Medical Officer · Directivos · 15 oct 2025 · Alkermes plc. 5000 títulos @ 19,34 US$ 1.1% de su flujo Ordinary Shares SEC:0001520262-25-000008:0
◇ EVP R&D, Chief Medical Officer · Directivos · 26 feb 2025 · Alkermes plc. 6866 títulos Ordinary Shares SEC:0001127602-25-007313:0
25 de 52 declaraciones
Ver más (27 restantes) About Hopkinson Craig C. Hopkinson Craig C. is an executive linked to Alkermes plc., where he is EVP R&D, Chief Medical Officer, and to Albireo Pharma, INC., where he is Director. He has 49 filings in total, and in the sampled recent filings from 2021-06-08 to 2026-07-01, sales amount to EUR 4017240 and the most frequent transaction nature is option exercise.